US20090228059A1 - Method and device for lymphatic system monitoring - Google Patents
Method and device for lymphatic system monitoring Download PDFInfo
- Publication number
- US20090228059A1 US20090228059A1 US12/430,211 US43021109A US2009228059A1 US 20090228059 A1 US20090228059 A1 US 20090228059A1 US 43021109 A US43021109 A US 43021109A US 2009228059 A1 US2009228059 A1 US 2009228059A1
- Authority
- US
- United States
- Prior art keywords
- lymphatic
- circuitry
- sensor
- controller
- therapy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/03—Detecting, measuring or recording fluid pressure within the body other than blood pressure, e.g. cerebral pressure; Measuring pressure in body tissues or organs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/07—Endoradiosondes
- A61B5/076—Permanent implantations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/14546—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring analytes not otherwise provided for, e.g. ions, cytochromes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/41—Detecting, measuring or recording for evaluating the immune or lymphatic systems
- A61B5/414—Evaluating particular organs or parts of the immune or lymphatic systems
- A61B5/415—Evaluating particular organs or parts of the immune or lymphatic systems the glands, e.g. tonsils, adenoids or thymus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/41—Detecting, measuring or recording for evaluating the immune or lymphatic systems
- A61B5/414—Evaluating particular organs or parts of the immune or lymphatic systems
- A61B5/418—Evaluating particular organs or parts of the immune or lymphatic systems lymph vessels, ducts or nodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/48—Other medical applications
- A61B5/4836—Diagnosis combined with treatment in closed-loop systems or methods
- A61B5/4839—Diagnosis combined with treatment in closed-loop systems or methods combined with drug delivery
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/362—Heart stimulators
- A61N1/365—Heart stimulators controlled by a physiological parameter, e.g. heart potential
- A61N1/36514—Heart stimulators controlled by a physiological parameter, e.g. heart potential controlled by a physiological quantity other than heart potential, e.g. blood pressure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0002—Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network
- A61B5/0031—Implanted circuitry
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/362—Heart stimulators
- A61N1/3627—Heart stimulators for treating a mechanical deficiency of the heart, e.g. congestive heart failure or cardiomyopathy
Definitions
- This invention pertains to methods and systems for diagnosing and treating disease with implantable devices.
- the lymphatic system and the cardiovascular system are closely related structures that are joined by a capillary system.
- the lymphatic system is important to the body's defense mechanisms by filtering out organisms that cause disease and producing lymphocytes that attack foreign organisms and generate antibodies. It is also important for the distribution of fluids and nutrients in the body, because it drains excess fluids and protein from interstitial tissues. Lymph is the fluid that seeps outside the blood vessels in interstitial spaces of body tissues and is then absorbed by lymphatic capillaries to flow back into the bloodstream through the lymphatic vessels.
- the terminal structures of the lymphatic vessels include the right lymphatic duct, which drains lymph fluid from the upper right quarter of the body above the diaphragm and down the midline, and the thoracic duct, located in the mediastinum of the pleural cavity which drains the rest of the body.
- the right lymphatic duct which drains lymph fluid from the upper right quarter of the body above the diaphragm and down the midline
- the thoracic duct located in the mediastinum of the pleural cavity which drains the rest of the body.
- An implantable device is configured with a lymphatic sensor disposed in a lymphatic vessel for sensing pressure, flow, and/or the concentration of particular markers within the vessel.
- the device may be further configured to deliver appropriate therapy in accordance with the lymphatic monitoring.
- FIG. 1 illustrates the physical placement of an implanted monitoring device and attached lead.
- FIG. 2 illustrates the components of an exemplary system for physiological monitoring of the lymphatic system.
- FIG. 3 illustrates a block diagram of the components of an exemplary implantable monitoring device.
- FIG. 4 illustrates an embodiment for delivering cardiac pacing therapy.
- lymphatic vessels are part of the body's circulatory system and serve as a pathway by which fluids can flow from the interstitial spaces into blood. Lymphatic vessels also communicate with lymph nodes and facilitate the body's immune function by transporting foreign antigens to the lymph nodes from the interstitial spaces. As described below, an implantable device may be used to monitor lymphatic function and thereby detect particular conditions such as increased inflammation and edema.
- lymphatic system One of the functions performed by the lymphatic system is the conveying back to the blood of fluid and proteins exuded from the blood vessels into the interstitial space. Exuded fluid and proteins are absorbed by lymphatic capillaries and then flow into the venous system through lymphatic vessels.
- the lymphatic system is normally very efficient at removing excess fluid from the interstitial space and is even able to maintain a slight negative pressure. Under certain conditions, however, the lymphatic system is so overwhelmed with fluid that a buildup occurs, referred to as edema. When edema occurs, pressure and flow within the lymphatic vessels increases. As described below, an implantable device may be configured to measure these parameters and detect edema.
- the concentration of particular molecules in the lymphatic fluid may also be detected by the device in order to further characterize edema or detect other clinical states of interest.
- the device may also be configured to deliver a specific therapy in response to the monitoring of lymphatic function, such as when edema is detected.
- a lymphatic function monitor may be incorporated as part of a cardiac pacing device configured to deliver cardiac resynchronization therapy (CRT) in which pacing pulses are used to overcome conduction deficits and cause the heart to contract in a more coordinated manner (e.g., biventricular pacing).
- CRT cardiac resynchronization therapy
- pacing pulses are used to overcome conduction deficits and cause the heart to contract in a more coordinated manner (e.g., biventricular pacing).
- CRT cardiac resynchronization therapy
- an implantable device configured to monitor lymphatic function may be further configured to initiate, increase, or modulate the delivery of CRT when edema is detected.
- the device could also be programmed to adjust certain CRT parameters such as the atrio-ventricular delay interval when edema is detected.
- Edema can also be caused by kidney disease or liver disease that results in decreased plasma proteins, particularly albumin. This causes increases osmotic pressure that forces more fluid from the blood capillaries into the interstitium.
- the device is configured to deliver an appropriate medication when edema is detected (e.g., an ACE inhibitor or angiotensin receptor blocker for the treatment of kidney disease.)
- the composition of lymphatic fluid may also be monitored to determine if particular clinical states exist. For example, the concentration of cytokines and immunoglobulins may be used to assess certain autoimmune diseases and cancer. When the concentration of such substances reaches a particular level, the device may then be configured to deliver an appropriate medication.
- FIG. 1 shows an exemplary physical placement of an implantable monitoring device as described herein.
- an implantable monitoring device 105 is placed subcutaneously on the patient's chest or abdomen, similar to a standard cardiac pacemaker.
- the monitoring device is connected to one or more leads 110 , each having a distal member that incorporates an electrode or sensor for sensing physiological parameter(s) related to lymphatic function, referred to herein as a lymphatic sensor.
- the lead is positioned within the lymphatic system using a venous approach which involves initial entry into the venous blood system.
- the lead 110 passes subcutaneously from the device housing 130 to a point of venous access in the upper chest or neck such as the subclavian vein.
- the lead is then guided into the thoracic duct ostium using standard fluoroscopy techniques and positioned at a selected location within the lymphatic system.
- An alternative implantation approach includes placing the lymphatic sensor using a direct surgical approach.
- FIG. 2 shows an exemplary monitoring system.
- the pulse monitoring device 105 includes a hermetically sealed housing 130 that is placed subcutaneously or submuscularly in a patient's chest or other convenient location as noted above.
- the housing 130 may be formed from a conductive metal, such as titanium, and may serve as an electrode for delivering electrical stimulation with a unipolar lead.
- a header 140 which may be formed of an insulating material, is mounted on the housing 130 for receiving the leads 110 which are electrically connected to the circuitry within the housing.
- Contained within the housing 130 is the electronic circuitry 132 for providing the functionality to the device as described herein which may include a power supply, monitoring circuitry, therapy circuitry, and a programmable electronic controller for controlling the operation of the device.
- FIG. 3 illustrates exemplary components of the electronic circuitry 132 depicted in FIG. 2 .
- a controller 135 is provided which may be made up of discrete circuit elements but is preferably a processing element such as a microprocessor together with associated memory for program and data storage which may be programmed to perform algorithms for delivering therapy. (As the terms are used herein, “circuitry” and “controller” may refer either to a programmed processor or to dedicated hardware components configured to perform a particular task.)
- the controller is interfaced to monitoring circuitry 136 from which it receives data generated by one or more lymphatic sensors 137 .
- the monitoring circuitry may include, for example, circuitry for amplification, filtering, and/or analog-to-digital conversion of voltages generated by a lymphatic sensor.
- the lymphatic sensor 137 is a flow or pressure sensor for sensing conditions within a lymphatic vessel that indicate edema may be present. As noted above, edema may be diagnosed when the lymphatic vessels are overwhelmed with fluid due to, for example, elevated venous pressure caused by heart failure and renal compensation thereof, kidney disease, or liver disease. Under such conditions, the pressure and/or flow of lymph within the lymphatic vessels may be increased.
- the lymphatic sensor is a chemo-sensor designed to generate a voltage proportional to the concentration of a particular chemical species. The chemo-sensor may be used to provide the controller an indication of the concentration of a particular molecule in the lymphatic fluid that is of interest, referred to as a marker.
- markers whose concentrations may be of diagnostic value include immunoglobulins, cytokines, or specific proteins that could be used to characterize a particular disease state.
- Such chemo-sensors may use immobilized antibodies with binding affinities specific for the different marker antigens.
- the chemo-sensor may produce an electrical signal by, for example, incorporating a piezoelectric transducer that responds to mechanical stresses induced by the Ab-Ag complex or a transducer that responds to potential changes resulting from the Ab-Ag complex.
- the lymphatic sensor is a stretch or volume sensor that monitors the degree of stretch or change in volume within a lymphatic vessel using impedance, ultrasonics, acoustic, capacitance, inductance, or optical-type instruments.
- the lymphatic sensor is a pulsatile rate sensor using impedance, ultrasonics, acoustic, piezoelectric, piezoresistive, capacitance, inductance, or optical type instruments to monitor pulsatile flow within a lymphatic vessel or a pulsatile contractility sensor that measures intensity of peristaltic wave motion using impedance, ultrasonics, acoustic, capacitance, inductance, or optical type instruments.
- the lymphatic sensor is a density sensor for detecting the concentration of dissolved and suspended particulates in the lymph fluid using an optical, acoustic, or electrical instrument. In another embodiment, the lymphatic sensor is a cell counting sensor that detects the density of lymphocytes in the lymph fluid.
- the controller 135 is also interfaced to therapy circuitry 140 in order to control the delivery of therapy by the device in response to conditions sensed by the monitoring circuitry.
- the therapy circuitry 135 may include circuitry for delivery of one or more therapy modalities such as cardiac resynchronization therapy, neural stimulation, and drug therapy.
- the device includes circuitry for delivering bradycardia cardiac pacing and/or cardiac resynchronization therapy and includes pulse generation circuitry 140 , cardiac sensing circuitry 142 , and pacing/sensing electrodes 111 electrically connected to the device by leads (i.e., intravenous leads such as shown in FIG. 1 ) adapted for disposition in the heart.
- the device includes a drug delivery device 145 actuated by the therapy circuitry that may be used to deliver medication in response detection of particular conditions. Such medications could include anti-inflammatory drugs, cancer chemotherapeutic agents, diuretics, or cardiac drugs.
- a telemetry transceiver 150 capable of communicating with an external programmer or a remote monitoring device 190 as illustrated in FIG. 2 .
- An external programmer wirelessly communicates with the device 105 and enables a clinician to receive data and modify the programming of the controller.
- a remote monitoring device similarly communicates with the device 105 and is further interfaced to a network 195 (e.g., an internet connection) for communicating with a patient management server 196 that allows clinical personnel at remote locations to receive data from the remote monitoring device as well as issue commands.
- the controller may be programmed such when particular conditions are detected by the monitoring circuitry (such as when a measured parameter exceeds or falls below a specified limit value), the device transmits an alarm message to the remote monitoring device and to the patient management server to alert clinical personnel.
- lymphatic system may be visualized using lymphangiography.
- dye is injected into the subcutaneous tissue of an extremity such as the foot, or other peripheral lymph vessel, and the lymphatic system drains the dye making the lymphatic vessels visible.
- a lymphatic vessel is cannulated, and radiopaque contrast is injected to illuminate major lymph vessels including the thoracic duct and its ostium into the subclavian vein.
- a catheter or the lead may then be guided into the thoracic duct ostium via the venous system using fluoroscopy techniques and positioned at a selected location within the lymphatic system.
- Initial cannulation of the lymph ostium with a guide wire or catheter may be achieved through the left or right subclavian vein, the left jugular veins, the epigastric/mammary veins or the femoral veins.
- an overlapping technique may be employed whereby fluoroscopic images produced by the injected dye are used in conjunction with anatomical images of the patient produced by other modalities such as conventional x-ray, CAT scans, MRI scans, or ultrasonic scans.
- the fluoroscopic image may be overlaid with the anatomical image and the lead then guided to the selected location.
- a catheter or the lead by itself may be introduced into the venous system and from there into the thoracic duct ostium using conventional over-the-wire techniques that employ a guide wire.
- the guide wire is manually or mechanically pushed and manipulated to guide its travel and upon which catheters and/or leads may be advanced.
- a stereotaxis technique in which external magnets or other means are used to guide the catheter may also be used to improve maneuverability and precision as well as provide increased safety. An example of this technique is described in U.S. Pat. No. 6,475,223, hereby incorporated by reference.
- the catheter or lead Once the catheter or lead is in the lymphatic system, it must also traverse valves in the lymphatic vessels whose function is to allow flow of lymphatic fluid in only one direction to the thoracic duct.
- the catheter may incorporate a vacuum system to open the valves. When the vacuum system is actuated, it draws negative pressure to create a pressure gradient that opens the valve.
- An alternative technique for opening lymphatic valves involves using a catheter incorporating a compliant balloon on its distal tip. When the catheter reaches a lymphatic valve, the balloon is inflated to mechanically dilate the vessel which opens the valve and allows a wire or the catheter to pass through.
- the catheter incorporates an electrode at its tip that is used to cause smooth muscle contraction of the lymphatic vessel. Such smooth muscle contraction can create a pressure gradient that opens the valve and allows the catheter to advance past the valve.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Heart & Thoracic Surgery (AREA)
- Public Health (AREA)
- Biophysics (AREA)
- Biomedical Technology (AREA)
- Physics & Mathematics (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pathology (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- Surgery (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Radiology & Medical Imaging (AREA)
- Optics & Photonics (AREA)
- Physiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Endocrinology (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Measuring And Recording Apparatus For Diagnosis (AREA)
- Electrotherapy Devices (AREA)
Abstract
A device and method are disclosed for physiological monitoring of the lymphatic system. An implantable device is configured with a lymphatic sensor disposed in a lymphatic vessel for sensing pressure, flow, and/or the concentration of particular markers within the vessel. The device may be further configured to deliver appropriate therapy in accordance with the lymphatic monitoring.
Description
- This application is a divisional of U.S. application Ser. No. 11/422,417, filed Jun. 6, 2006, which is hereby incorporated by reference in its entirety.
- This application is related to co-pending application Ser. Nos. 11/422,423, 11/422,414, 11/422,418, and 11/422,421 all filed Jun. 6, 2006 and hereby incorporated by reference.
- This invention pertains to methods and systems for diagnosing and treating disease with implantable devices.
- The lymphatic system and the cardiovascular system are closely related structures that are joined by a capillary system. The lymphatic system is important to the body's defense mechanisms by filtering out organisms that cause disease and producing lymphocytes that attack foreign organisms and generate antibodies. It is also important for the distribution of fluids and nutrients in the body, because it drains excess fluids and protein from interstitial tissues. Lymph is the fluid that seeps outside the blood vessels in interstitial spaces of body tissues and is then absorbed by lymphatic capillaries to flow back into the bloodstream through the lymphatic vessels. The terminal structures of the lymphatic vessels include the right lymphatic duct, which drains lymph fluid from the upper right quarter of the body above the diaphragm and down the midline, and the thoracic duct, located in the mediastinum of the pleural cavity which drains the rest of the body. Through the flow of blood in and out of arteries, into the veins, and through the lymph vessels and nodes, the body is able to eliminate the products of cellular breakdown and bacterial invasion.
- A device and method are disclosed for physiological monitoring of the lymphatic system. An implantable device is configured with a lymphatic sensor disposed in a lymphatic vessel for sensing pressure, flow, and/or the concentration of particular markers within the vessel. The device may be further configured to deliver appropriate therapy in accordance with the lymphatic monitoring.
-
FIG. 1 illustrates the physical placement of an implanted monitoring device and attached lead. -
FIG. 2 illustrates the components of an exemplary system for physiological monitoring of the lymphatic system. -
FIG. 3 illustrates a block diagram of the components of an exemplary implantable monitoring device. -
FIG. 4 illustrates an embodiment for delivering cardiac pacing therapy. - This disclosure relates to a device and method for monitoring lymphatic function. The lymphatic vessels are part of the body's circulatory system and serve as a pathway by which fluids can flow from the interstitial spaces into blood. Lymphatic vessels also communicate with lymph nodes and facilitate the body's immune function by transporting foreign antigens to the lymph nodes from the interstitial spaces. As described below, an implantable device may be used to monitor lymphatic function and thereby detect particular conditions such as increased inflammation and edema.
- One of the functions performed by the lymphatic system is the conveying back to the blood of fluid and proteins exuded from the blood vessels into the interstitial space. Exuded fluid and proteins are absorbed by lymphatic capillaries and then flow into the venous system through lymphatic vessels. The lymphatic system is normally very efficient at removing excess fluid from the interstitial space and is even able to maintain a slight negative pressure. Under certain conditions, however, the lymphatic system is so overwhelmed with fluid that a buildup occurs, referred to as edema. When edema occurs, pressure and flow within the lymphatic vessels increases. As described below, an implantable device may be configured to measure these parameters and detect edema. The concentration of particular molecules in the lymphatic fluid may also be detected by the device in order to further characterize edema or detect other clinical states of interest. The device may also be configured to deliver a specific therapy in response to the monitoring of lymphatic function, such as when edema is detected.
- In one embodiment, a lymphatic function monitor may be incorporated as part of a cardiac pacing device configured to deliver cardiac resynchronization therapy (CRT) in which pacing pulses are used to overcome conduction deficits and cause the heart to contract in a more coordinated manner (e.g., biventricular pacing). CRT is commonly used to treat patients with chronic heart failure. When chronic heart failure worsens, the decreased cardiac output causes diminished renal perfusion. The kidneys compensate for this by absorbing more salt and water from the renal filtrate which raises venous pressure. The increased venous pressure then results in edema when the fluid buildup into the interstitial space overcomes the lymphatic system's ability to remove it. Edema due to heart failure may occur, for example, in the lung or in the extremities. In one embodiment, an implantable device configured to monitor lymphatic function may be further configured to initiate, increase, or modulate the delivery of CRT when edema is detected. The device could also be programmed to adjust certain CRT parameters such as the atrio-ventricular delay interval when edema is detected.
- Edema can also be caused by kidney disease or liver disease that results in decreased plasma proteins, particularly albumin. This causes increases osmotic pressure that forces more fluid from the blood capillaries into the interstitium. In another embodiment, the device is configured to deliver an appropriate medication when edema is detected (e.g., an ACE inhibitor or angiotensin receptor blocker for the treatment of kidney disease.)
- The composition of lymphatic fluid may also be monitored to determine if particular clinical states exist. For example, the concentration of cytokines and immunoglobulins may be used to assess certain autoimmune diseases and cancer. When the concentration of such substances reaches a particular level, the device may then be configured to deliver an appropriate medication.
-
FIG. 1 shows an exemplary physical placement of an implantable monitoring device as described herein. In one embodiment, animplantable monitoring device 105 is placed subcutaneously on the patient's chest or abdomen, similar to a standard cardiac pacemaker. The monitoring device is connected to one ormore leads 110, each having a distal member that incorporates an electrode or sensor for sensing physiological parameter(s) related to lymphatic function, referred to herein as a lymphatic sensor. The lead is positioned within the lymphatic system using a venous approach which involves initial entry into the venous blood system. In the embodiment depicted inFIG. 1 , thelead 110 passes subcutaneously from the device housing 130 to a point of venous access in the upper chest or neck such as the subclavian vein. The lead is then guided into the thoracic duct ostium using standard fluoroscopy techniques and positioned at a selected location within the lymphatic system. An alternative implantation approach includes placing the lymphatic sensor using a direct surgical approach. -
FIG. 2 shows an exemplary monitoring system. Thepulse monitoring device 105 includes a hermetically sealedhousing 130 that is placed subcutaneously or submuscularly in a patient's chest or other convenient location as noted above. Thehousing 130 may be formed from a conductive metal, such as titanium, and may serve as an electrode for delivering electrical stimulation with a unipolar lead. Aheader 140, which may be formed of an insulating material, is mounted on thehousing 130 for receiving theleads 110 which are electrically connected to the circuitry within the housing. Contained within thehousing 130 is theelectronic circuitry 132 for providing the functionality to the device as described herein which may include a power supply, monitoring circuitry, therapy circuitry, and a programmable electronic controller for controlling the operation of the device. -
FIG. 3 illustrates exemplary components of theelectronic circuitry 132 depicted inFIG. 2 . Acontroller 135 is provided which may be made up of discrete circuit elements but is preferably a processing element such as a microprocessor together with associated memory for program and data storage which may be programmed to perform algorithms for delivering therapy. (As the terms are used herein, “circuitry” and “controller” may refer either to a programmed processor or to dedicated hardware components configured to perform a particular task.) The controller is interfaced tomonitoring circuitry 136 from which it receives data generated by one or morelymphatic sensors 137. The monitoring circuitry may include, for example, circuitry for amplification, filtering, and/or analog-to-digital conversion of voltages generated by a lymphatic sensor. - In one embodiment, the
lymphatic sensor 137 is a flow or pressure sensor for sensing conditions within a lymphatic vessel that indicate edema may be present. As noted above, edema may be diagnosed when the lymphatic vessels are overwhelmed with fluid due to, for example, elevated venous pressure caused by heart failure and renal compensation thereof, kidney disease, or liver disease. Under such conditions, the pressure and/or flow of lymph within the lymphatic vessels may be increased. In another embodiment, the lymphatic sensor is a chemo-sensor designed to generate a voltage proportional to the concentration of a particular chemical species. The chemo-sensor may be used to provide the controller an indication of the concentration of a particular molecule in the lymphatic fluid that is of interest, referred to as a marker. Examples of markers whose concentrations may be of diagnostic value include immunoglobulins, cytokines, or specific proteins that could be used to characterize a particular disease state. Such chemo-sensors may use immobilized antibodies with binding affinities specific for the different marker antigens. Upon formation of an Ab-Ag complex between the antibody and the marker, the chemo-sensor may produce an electrical signal by, for example, incorporating a piezoelectric transducer that responds to mechanical stresses induced by the Ab-Ag complex or a transducer that responds to potential changes resulting from the Ab-Ag complex. - In another embodiment, the lymphatic sensor is a stretch or volume sensor that monitors the degree of stretch or change in volume within a lymphatic vessel using impedance, ultrasonics, acoustic, capacitance, inductance, or optical-type instruments. In another embodiment, the lymphatic sensor is a pulsatile rate sensor using impedance, ultrasonics, acoustic, piezoelectric, piezoresistive, capacitance, inductance, or optical type instruments to monitor pulsatile flow within a lymphatic vessel or a pulsatile contractility sensor that measures intensity of peristaltic wave motion using impedance, ultrasonics, acoustic, capacitance, inductance, or optical type instruments. In another embodiment, the lymphatic sensor is a density sensor for detecting the concentration of dissolved and suspended particulates in the lymph fluid using an optical, acoustic, or electrical instrument. In another embodiment, the lymphatic sensor is a cell counting sensor that detects the density of lymphocytes in the lymph fluid.
- In the embodiment illustrated in
FIG. 3 , thecontroller 135 is also interfaced totherapy circuitry 140 in order to control the delivery of therapy by the device in response to conditions sensed by the monitoring circuitry. Thetherapy circuitry 135 may include circuitry for delivery of one or more therapy modalities such as cardiac resynchronization therapy, neural stimulation, and drug therapy. In one embodiment, shown inFIG. 4 , the device includes circuitry for delivering bradycardia cardiac pacing and/or cardiac resynchronization therapy and includespulse generation circuitry 140,cardiac sensing circuitry 142, and pacing/sensing electrodes 111 electrically connected to the device by leads (i.e., intravenous leads such as shown inFIG. 1 ) adapted for disposition in the heart. In another embodiment, the device includes adrug delivery device 145 actuated by the therapy circuitry that may be used to deliver medication in response detection of particular conditions. Such medications could include anti-inflammatory drugs, cancer chemotherapeutic agents, diuretics, or cardiac drugs. - Also interfaced to the controller in
FIG. 3 is atelemetry transceiver 150 capable of communicating with an external programmer or aremote monitoring device 190 as illustrated inFIG. 2 . An external programmer wirelessly communicates with thedevice 105 and enables a clinician to receive data and modify the programming of the controller. A remote monitoring device similarly communicates with thedevice 105 and is further interfaced to a network 195 (e.g., an internet connection) for communicating with apatient management server 196 that allows clinical personnel at remote locations to receive data from the remote monitoring device as well as issue commands. The controller may be programmed such when particular conditions are detected by the monitoring circuitry (such as when a measured parameter exceeds or falls below a specified limit value), the device transmits an alarm message to the remote monitoring device and to the patient management server to alert clinical personnel. - In order to implant a lead incorporating a lymphatic sensor(s) into a selected location within lymphatic vessel, the lymphatic system may be visualized using lymphangiography. In this technique, dye is injected into the subcutaneous tissue of an extremity such as the foot, or other peripheral lymph vessel, and the lymphatic system drains the dye making the lymphatic vessels visible. A lymphatic vessel is cannulated, and radiopaque contrast is injected to illuminate major lymph vessels including the thoracic duct and its ostium into the subclavian vein. A catheter or the lead may then be guided into the thoracic duct ostium via the venous system using fluoroscopy techniques and positioned at a selected location within the lymphatic system. Initial cannulation of the lymph ostium with a guide wire or catheter may be achieved through the left or right subclavian vein, the left jugular veins, the epigastric/mammary veins or the femoral veins. In order to facilitate navigation through the lymphatic vessels and position the sensor at a selected anatomical location, an overlapping technique may be employed whereby fluoroscopic images produced by the injected dye are used in conjunction with anatomical images of the patient produced by other modalities such as conventional x-ray, CAT scans, MRI scans, or ultrasonic scans. The fluoroscopic image may be overlaid with the anatomical image and the lead then guided to the selected location.
- To implant the lead, a catheter or the lead by itself may be introduced into the venous system and from there into the thoracic duct ostium using conventional over-the-wire techniques that employ a guide wire. The guide wire is manually or mechanically pushed and manipulated to guide its travel and upon which catheters and/or leads may be advanced. A stereotaxis technique in which external magnets or other means are used to guide the catheter may also be used to improve maneuverability and precision as well as provide increased safety. An example of this technique is described in U.S. Pat. No. 6,475,223, hereby incorporated by reference. Once the catheter or lead is in the lymphatic system, it must also traverse valves in the lymphatic vessels whose function is to allow flow of lymphatic fluid in only one direction to the thoracic duct. In the case where a catheter is employed, as the catheter is guided through a vessel to one of these valves, the catheter may incorporate a vacuum system to open the valves. When the vacuum system is actuated, it draws negative pressure to create a pressure gradient that opens the valve. An alternative technique for opening lymphatic valves involves using a catheter incorporating a compliant balloon on its distal tip. When the catheter reaches a lymphatic valve, the balloon is inflated to mechanically dilate the vessel which opens the valve and allows a wire or the catheter to pass through. In still another technique, the catheter incorporates an electrode at its tip that is used to cause smooth muscle contraction of the lymphatic vessel. Such smooth muscle contraction can create a pressure gradient that opens the valve and allows the catheter to advance past the valve.
- Although the invention has been described in conjunction with the foregoing specific embodiments, many alternatives, variations, and modifications will be apparent to those of ordinary skill in the art. Such alternatives, variations, and modifications are intended to fall within the scope of the following appended claims.
Claims (12)
1. A device, comprising:
monitoring and therapy circuitry contained within an implantable housing;
a lead electrically connected to the monitoring circuitry that is adapted for implantation into a lymphatic vessel, the lead having a lymphatic sensor incorporated therein for sensing a physiological parameter related to lymphatic function;
a controller interfaced to the therapy circuitry and interfaced to the monitoring circuitry for processing sensing signals generated by the lymphatic sensor;
wherein the controller is programmed to modify the delivery of therapy when edema is detected from the lymphatic sensor signals.
2. The device of claim 1 wherein the lymphatic sensor is a pressure sensor.
3. The device of claim 1 wherein the lymphatic sensor is a flow sensor.
4. The device of claim 1 wherein the lymphatic sensor is a chemo-sensor for generating a voltage proportional to the concentration of a particular chemical species in the lymphatic fluid.
5. The device of claim 1 further comprising a telemetry transceiver interfaced to the controller for enabling wireless communication with the controller.
6. The device of claim 5 wherein the controller is programmed to transmit an alarm message via the telemetry transceiver if a value sensed by the lymphatic sensor reaches a specified limit value.
7. The device of claim 1 wherein the therapy circuitry comprises:
cardiac pacing circuitry, including pulse generation circuitry and cardiac sensing circuitry;
one or more leads with pacing/sensing electrodes electrically connected to the cardiac pacing circuitry; and,
wherein the controller is programmed to deliver bradycardia pacing therapy based upon sensing signals generated by the lymphatic sensor.
8. The device of claim 1 wherein the therapy circuitry comprises:
pulse generation circuitry;
one or more leads with electrodes electrically connected to the pulse generation circuitry for delivering neural stimulation; and,
wherein the controller is programmed to deliver neural stimulation therapy based upon sensing signals generated by the lymphatic sensor.
9. The device of claim 1 wherein the therapy circuitry comprises:
a drug delivery device actuated by the therapy circuitry; and,
wherein the controller is programmed to deliver medication based upon sensing signals generated by the lymphatic sensor.
10. The device of claim 1 wherein the therapy circuitry comprises:
cardiac pacing circuitry, including pulse generation circuitry and cardiac sensing circuitry;
one or more leads with pacing/sensing electrodes electrically connected to the cardiac pacing circuitry; and,
wherein the controller is programmed to deliver cardiac resynchronization therapy based upon sensing signals generated by the lymphatic sensor.
11. The device of claim 10 wherein the controller is programmed to initiate, or increase, the delivery of cardiac resynchronization therapy upon sensing a lymphatic flow or pressure value indicative of edema.
12. The device of claim 10 wherein the controller is programmed to adjust one or more cardiac resynchronization parameters upon sensing a lymphatic flow or pressure value indicative of edema.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12/430,211 US20090228059A1 (en) | 2006-06-06 | 2009-04-27 | Method and device for lymphatic system monitoring |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11/422,417 US7526337B2 (en) | 2006-06-06 | 2006-06-06 | Method and device for lymphatic system monitoring |
US12/430,211 US20090228059A1 (en) | 2006-06-06 | 2009-04-27 | Method and device for lymphatic system monitoring |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/422,417 Division US7526337B2 (en) | 2006-06-06 | 2006-06-06 | Method and device for lymphatic system monitoring |
Publications (1)
Publication Number | Publication Date |
---|---|
US20090228059A1 true US20090228059A1 (en) | 2009-09-10 |
Family
ID=38623969
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/422,417 Expired - Fee Related US7526337B2 (en) | 2006-06-06 | 2006-06-06 | Method and device for lymphatic system monitoring |
US12/430,211 Abandoned US20090228059A1 (en) | 2006-06-06 | 2009-04-27 | Method and device for lymphatic system monitoring |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/422,417 Expired - Fee Related US7526337B2 (en) | 2006-06-06 | 2006-06-06 | Method and device for lymphatic system monitoring |
Country Status (4)
Country | Link |
---|---|
US (2) | US7526337B2 (en) |
EP (1) | EP2029003A2 (en) |
JP (1) | JP5235014B2 (en) |
WO (1) | WO2007146489A2 (en) |
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20070282386A1 (en) * | 2006-06-06 | 2007-12-06 | Shuros Allan C | Method and apparatus for gastrointestinal stimulation via the lymphatic system |
US20070282390A1 (en) * | 2006-06-06 | 2007-12-06 | Shuros Allan C | Amelioration of chronic pain by endolymphatic stimulation |
US20080009719A1 (en) * | 2006-06-06 | 2008-01-10 | Shuros Allan C | Method and apparatus for introducing endolymphatic instrumentation |
US20080195171A1 (en) * | 2007-02-13 | 2008-08-14 | Sharma Virender K | Method and Apparatus for Electrical Stimulation of the Pancreatico-Biliary System |
US20110276023A1 (en) * | 2010-05-04 | 2011-11-10 | Leeflang Stephen A | Apparatus and Methods for Accessing the Lymphatic System |
US8369943B2 (en) | 2006-06-06 | 2013-02-05 | Cardiac Pacemakers, Inc. | Method and apparatus for neural stimulation via the lymphatic system |
US8905999B2 (en) | 2006-09-01 | 2014-12-09 | Cardiac Pacemakers, Inc. | Method and apparatus for endolymphatic drug delivery |
WO2015200797A3 (en) * | 2014-06-26 | 2016-02-18 | The Trustees Of The University Of Pennsylvania | Devices and methods for alleviating lymphatic system congestion |
US10376694B2 (en) | 2008-10-09 | 2019-08-13 | Virender K. Sharma | Method and apparatus for stimulating the vascular system |
US10603489B2 (en) | 2008-10-09 | 2020-03-31 | Virender K. Sharma | Methods and apparatuses for stimulating blood vessels in order to control, treat, and/or prevent a hemorrhage |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7526337B2 (en) | 2006-06-06 | 2009-04-28 | Cardiac Pacemakers, Inc. | Method and device for lymphatic system monitoring |
US20080294228A1 (en) * | 2007-05-23 | 2008-11-27 | Cardiac Pacemakers | Method and device for controlled stimulation of lymphatic flow |
US8105261B2 (en) | 2007-07-02 | 2012-01-31 | Cardiac Pacemakers, Inc. | Osmotic devices and methods for diuretic therapy |
EP2362747A1 (en) | 2008-09-23 | 2011-09-07 | Cardiac Pacemakers, Inc. | Method and apparatus for organ specific inflammation monitoring |
WO2010080717A1 (en) | 2009-01-12 | 2010-07-15 | The Board Of Trustees Of The Leland Stanford Junior University | Drainage device and method |
US20100256700A1 (en) * | 2009-04-07 | 2010-10-07 | Shuros Allan C | Method and apparatus for organ specific inflammation therapy |
EP2436306B1 (en) * | 2009-05-29 | 2015-09-30 | National University Corporation Hamamatsu University School of Medicine | Lymphatic pressure-measuring system and method for controlling same |
US10052059B2 (en) | 2011-05-03 | 2018-08-21 | Matthew J. Callaghan | Apparatus and methods for accessing the lymphatic system |
US10111997B2 (en) | 2011-05-03 | 2018-10-30 | Matthew J. Callaghan | Apparatus and methods for accessing the lymphatic system |
US10688236B2 (en) | 2013-01-21 | 2020-06-23 | Lxs, Llc | Systems and methods for performing medical procedures involving accessing the lymphatic system |
WO2014145301A1 (en) * | 2013-03-15 | 2014-09-18 | Matthew John Callaghan | Apparatus and methods for accessing the lymphatic system |
EP3003455B1 (en) | 2013-06-08 | 2023-08-30 | Lxs, Llc | Systems for performing medical procedures involving accessing the lymphatic system |
US9901722B2 (en) | 2014-06-01 | 2018-02-27 | White Swell Medical Ltd | System and method for treatment of pulmonary edema |
EP3294369B1 (en) | 2015-05-11 | 2021-09-01 | White Swell Medical Ltd | Systems for reducing pressure at an outflow of a duct |
CN109362224B (en) * | 2016-04-04 | 2022-09-13 | 通用电气公司 | Neuromodulation techniques |
CN110167612B (en) | 2016-11-01 | 2022-06-17 | 怀特斯维尔医疗有限公司 | System and method for handling fluid overload |
US10912873B2 (en) | 2017-03-02 | 2021-02-09 | White Swell Medical Ltd | Systems and methods for reducing pressure at an outflow of a duct |
WO2018172848A2 (en) | 2017-03-19 | 2018-09-27 | White Swell Medical Ltd | Methods and devices for reducing pressure |
US11717652B2 (en) | 2019-02-26 | 2023-08-08 | White Swell Medical Ltd | Devices and methods for treating edema |
US11724095B2 (en) | 2019-02-26 | 2023-08-15 | White Swell Medical Ltd | Devices and methods for treating edema |
US11793996B2 (en) | 2019-02-26 | 2023-10-24 | White Swell Medical Ltd | Devices and methods for treating edema |
US11660426B2 (en) | 2019-02-26 | 2023-05-30 | White Swell Medical Ltd | Devices and methods for treating edema |
US11931560B2 (en) | 2019-02-26 | 2024-03-19 | White Swell Medical Ltd | Devices and methods for treating edema |
Citations (95)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3814080A (en) * | 1972-11-13 | 1974-06-04 | Becton Dickinson Co | Vessel cannulator and clamp for lymphangiography |
US3916875A (en) * | 1974-01-02 | 1975-11-04 | Herbert Toch | Lymph duct cannulation facilitator |
US4650467A (en) * | 1984-08-22 | 1987-03-17 | Sarcem S.A. | Remote control catheter |
US4792330A (en) * | 1987-07-13 | 1988-12-20 | Lazarus Medical Innovations, Inc. | Combination catheter and duct clamp apparatus and method |
US4909787A (en) * | 1986-08-14 | 1990-03-20 | Danforth John W | Controllable flexibility catheter with eccentric stiffener |
US4957484A (en) * | 1988-07-26 | 1990-09-18 | Automedix Sciences, Inc. | Lymph access catheters and methods of administration |
US5112303A (en) * | 1991-05-02 | 1992-05-12 | Pudenz-Schulte Medical Research Corporation | Tumor access device and method for delivering medication into a body cavity |
US5284153A (en) * | 1992-04-14 | 1994-02-08 | Brigham And Women's Hospital | Method for locating a nerve and for protecting nerves from injury during surgery |
US5305745A (en) * | 1988-06-13 | 1994-04-26 | Fred Zacouto | Device for protection against blood-related disorders, notably thromboses, embolisms, vascular spasms, hemorrhages, hemopathies and the presence of abnormal elements in the blood |
US5333609A (en) * | 1992-05-19 | 1994-08-02 | Minnesota Mining And Manufacturing Company | Catheter and probe-catheter assembly |
US5387231A (en) * | 1992-07-21 | 1995-02-07 | Sporer; Patsy | Electrotherapy method |
US5391143A (en) * | 1993-03-12 | 1995-02-21 | Kensey Nash Corporation | Method and system for effecting weight reduction of living beings |
US5405363A (en) * | 1991-03-15 | 1995-04-11 | Angelon Corporation | Implantable cardioverter defibrillator having a smaller displacement volume |
US5596988A (en) * | 1993-06-30 | 1997-01-28 | Biomedical Sensors, Ltd. | Multi-parameter sensor apparatus |
US5655548A (en) * | 1996-09-16 | 1997-08-12 | Circulation, Inc. | Method for treatment of ischemic heart disease by providing transvenous myocardial perfusion |
US5658318A (en) * | 1994-06-24 | 1997-08-19 | Pacesetter Ab | Method and apparatus for detecting a state of imminent cardiac arrhythmia in response to a nerve signal from the autonomic nerve system to the heart, and for administrating anti-arrhythmia therapy in response thereto |
US5662689A (en) * | 1995-09-08 | 1997-09-02 | Medtronic, Inc. | Method and apparatus for alleviating cardioversion shock pain |
US5697953A (en) * | 1993-03-13 | 1997-12-16 | Angeion Corporation | Implantable cardioverter defibrillator having a smaller displacement volume |
US5817138A (en) * | 1996-11-27 | 1998-10-06 | Suzuki; James Y. | Multi-channel, interferential wave, micro current device and methods for treatment using micro current |
US5865744A (en) * | 1996-09-16 | 1999-02-02 | Lemelson; Jerome H. | Method and system for delivering therapeutic agents |
US5891084A (en) * | 1994-12-27 | 1999-04-06 | Lee; Vincent W. | Multiple chamber catheter delivery system |
US6024704A (en) * | 1998-04-30 | 2000-02-15 | Medtronic, Inc | Implantable medical device for sensing absolute blood pressure and barometric pressure |
US6077227A (en) * | 1998-12-28 | 2000-06-20 | Medtronic, Inc. | Method for manufacture and implant of an implantable blood vessel cuff |
US6106477A (en) * | 1998-12-28 | 2000-08-22 | Medtronic, Inc. | Chronically implantable blood vessel cuff with sensor |
US6115637A (en) * | 1998-12-22 | 2000-09-05 | Universities Research Association, Inc. | Microcurrent therapeutic technique for treatment of radiation toxicity |
US6129685A (en) * | 1994-02-09 | 2000-10-10 | The University Of Iowa Research Foundation | Stereotactic hypothalamic obesity probe |
US6238423B1 (en) * | 1997-01-13 | 2001-05-29 | Medtronic, Inc. | Apparatus and method for treating chronic constipation |
US20010007924A1 (en) * | 1999-12-28 | 2001-07-12 | Tanita Corporation | Apparatus for detemining degree of restoration of diseased part |
US6272370B1 (en) * | 1998-08-07 | 2001-08-07 | The Regents Of University Of Minnesota | MR-visible medical device for neurological interventions using nonlinear magnetic stereotaxis and a method imaging |
US6292695B1 (en) * | 1998-06-19 | 2001-09-18 | Wilton W. Webster, Jr. | Method and apparatus for transvascular treatment of tachycardia and fibrillation |
US20010037061A1 (en) * | 2000-04-28 | 2001-11-01 | Rolf Eckmiller | Microcontact structure for neuroprostheses for implantation on nerve tissue and method therefor |
US20010041870A1 (en) * | 1999-03-09 | 2001-11-15 | Edward M. Gillis | Implantable device for access to a treatment site |
US6321109B2 (en) * | 1996-02-15 | 2001-11-20 | Biosense, Inc. | Catheter based surgery |
US20020016615A1 (en) * | 1998-05-08 | 2002-02-07 | Dev Nagendu B. | Electrically induced vessel vasodilation |
US20020029037A1 (en) * | 2000-09-06 | 2002-03-07 | Kim Young D. | Method and apparatus for percutaneous trans-endocardial reperfusion |
US6368274B1 (en) * | 1999-07-01 | 2002-04-09 | Medtronic Minimed, Inc. | Reusable analyte sensor site and method of using the same |
US6370417B1 (en) * | 1998-09-22 | 2002-04-09 | Siemens Akiengesellschaft | Method for positioning a catheter in a vessel, and device for implementing the method |
US20020123674A1 (en) * | 2001-03-01 | 2002-09-05 | Gianni Plicchi | Process and implantable device for the intrapulmonary assessing of density dependant physical properties of the lung tissue |
US20020156462A1 (en) * | 2001-04-18 | 2002-10-24 | Stultz Mark R. | Programmable implantable pump with accessory reservoirs and multiple independent lumen catheter |
US6475223B1 (en) * | 1997-08-29 | 2002-11-05 | Stereotaxis, Inc. | Method and apparatus for magnetically controlling motion direction of a mechanically pushed catheter |
US20020188253A1 (en) * | 2001-06-07 | 2002-12-12 | Pharmaspec Corporation | Method and apparatus for drug delivery in veins |
US20030018247A1 (en) * | 2001-06-29 | 2003-01-23 | George Gonzalez | Process for testing and treating aberrant sensory afferents and motors efferents |
US20030036773A1 (en) * | 2001-08-03 | 2003-02-20 | Whitehurst Todd K. | Systems and methods for treatment of coronary artery disease |
US20030078623A1 (en) * | 2001-10-22 | 2003-04-24 | Weinberg Lisa P. | Implantable lead and method for stimulating the vagus nerve |
US20030105506A1 (en) * | 2001-12-04 | 2003-06-05 | Cardiac Pacemakers, Inc. | Apparatus and method for stabilizing an implantable lead |
US20030113303A1 (en) * | 1998-02-05 | 2003-06-19 | Yitzhack Schwartz | Homing of embryonic stem cells to a target zone in tissue using active therapeutics or substances |
US6584362B1 (en) * | 2000-08-30 | 2003-06-24 | Cardiac Pacemakers, Inc. | Leads for pacing and/or sensing the heart from within the coronary veins |
US6629534B1 (en) * | 1999-04-09 | 2003-10-07 | Evalve, Inc. | Methods and apparatus for cardiac valve repair |
US20030204185A1 (en) * | 2002-04-26 | 2003-10-30 | Sherman Marshall L. | System and method for monitoring use of disposable catheters |
US20040006795A1 (en) * | 2002-06-13 | 2004-01-08 | Mcgonigle Brian | Methods to increase the isoflavonoid levels in plants and plants producing increased levels of isoflavonoids |
US6676686B2 (en) * | 2000-04-25 | 2004-01-13 | Harumi Naganuma | Noninvasive detection and activation of the lymphatic system in treating disease and alleviating pain |
US6741882B2 (en) * | 1999-12-02 | 2004-05-25 | Koninklijke Philips Electronics N.V. | MR device and MR method for localizing and/or visualizing a medical instrument provided with a passive magnet device |
US20040102804A1 (en) * | 1999-08-10 | 2004-05-27 | Chin Albert K. | Apparatus and methods for endoscopic surgical procedures |
US20040106953A1 (en) * | 2002-10-04 | 2004-06-03 | Yomtov Barry M. | Medical device for controlled drug delivery and cardiac monitoring and/or stimulation |
US20040158297A1 (en) * | 2001-06-29 | 2004-08-12 | George Gonzalez | Process for testing and treating motor and muscle function, sensory, autonomic, cognitive and neurologic disorders |
US20040172080A1 (en) * | 2002-12-04 | 2004-09-02 | Stadler Robert W. | Method and apparatus for detecting change in intrathoracic electrical impedance |
US20040172102A1 (en) * | 2000-04-13 | 2004-09-02 | Cochlear Limited | At least partially implantable system for rehabilitation of a hearing disorder |
US6804558B2 (en) * | 1999-07-07 | 2004-10-12 | Medtronic, Inc. | System and method of communicating between an implantable medical device and a remote computer system or health care provider |
US20040210118A1 (en) * | 2003-04-18 | 2004-10-21 | Michel Letort | In situ detection of endoleak and endotension |
US6835194B2 (en) * | 1999-03-18 | 2004-12-28 | Durect Corporation | Implantable devices and methods for treatment of pain by delivery of fentanyl and fentanyl congeners |
US20050043675A1 (en) * | 2003-08-21 | 2005-02-24 | Pastore Joseph M. | Method and apparatus for modulating cellular metabolism during post-ischemia or heart failure |
US20050043894A1 (en) * | 2003-08-22 | 2005-02-24 | Fernandez Dennis S. | Integrated biosensor and simulation system for diagnosis and therapy |
US20050049472A1 (en) * | 2003-08-29 | 2005-03-03 | Medtronic, Inc. | Implantable biosensor devices for monitoring cardiac marker molecules |
US20050075702A1 (en) * | 2003-10-01 | 2005-04-07 | Medtronic, Inc. | Device and method for inhibiting release of pro-inflammatory mediator |
US20050075701A1 (en) * | 2003-10-01 | 2005-04-07 | Medtronic, Inc. | Device and method for attenuating an immune response |
US20050080346A1 (en) * | 2002-12-16 | 2005-04-14 | The Regents Of The University Of Michigan | Antenna stent device for wireless, intraluminal monitoring |
US6893429B2 (en) * | 2001-08-30 | 2005-05-17 | Medtronic, Inc. | Convection enhanced delivery catheter to treat brain and other tumors |
US20050143765A1 (en) * | 2002-09-04 | 2005-06-30 | Endoart Sa | Telemetrically controlled band for regulating functioning of a body organ or duct, and methods of making, implantation and use |
US20050149014A1 (en) * | 2001-11-15 | 2005-07-07 | Quantumcor, Inc. | Cardiac valve leaflet attachment device and methods thereof |
US6918873B1 (en) * | 2002-09-19 | 2005-07-19 | Millar Instruments, Inc. | Inverted sensor module |
US20050187584A1 (en) * | 2001-01-16 | 2005-08-25 | Stephen Denker | Vagal nerve stimulation using vascular implanted devices for treatment of atrial fibrillation |
US20050240243A1 (en) * | 2004-02-25 | 2005-10-27 | Giancarlo Barolat | System and method for neurological stimulation of peripheral nerves to treat low back pain |
US20050246006A1 (en) * | 2004-04-30 | 2005-11-03 | Algotec Limited | Electrical nerve stimulation device |
US20050261741A1 (en) * | 2004-05-20 | 2005-11-24 | Imad Libbus | Combined remodeling control therapy and anti-remodeling therapy by implantable cardiac device |
US20050267440A1 (en) * | 2004-06-01 | 2005-12-01 | Herman Stephen J | Devices and methods for measuring and enhancing drug or analyte transport to/from medical implant |
US20060020333A1 (en) * | 2004-05-05 | 2006-01-26 | Lashinski Randall T | Method of in situ formation of translumenally deployable heart valve support |
US20060030837A1 (en) * | 2004-01-29 | 2006-02-09 | The Charles Stark Draper Laboratory, Inc. | Drug delivery apparatus |
US20060074453A1 (en) * | 2004-10-04 | 2006-04-06 | Cvrx, Inc. | Baroreflex activation and cardiac resychronization for heart failure treatment |
US20060149337A1 (en) * | 2005-01-21 | 2006-07-06 | John Michael S | Systems and methods for tissue stimulation in medical treatment |
US20060149331A1 (en) * | 2003-12-19 | 2006-07-06 | Brian Mann | Method for digital cardiac rhythm management |
US7123961B1 (en) * | 2002-06-13 | 2006-10-17 | Pacesetter, Inc. | Stimulation of autonomic nerves |
US20060247601A1 (en) * | 2005-04-19 | 2006-11-02 | Ellin Philip J | Method of improved drug delivery and for treatment of cellulitis |
US20070021731A1 (en) * | 1997-11-12 | 2007-01-25 | Garibaldi Jeffrey M | Method of and apparatus for navigating medical devices in body lumens |
US20070027460A1 (en) * | 2005-07-27 | 2007-02-01 | Cook Incorporated | Implantable remodelable materials comprising magnetic material |
US7277761B2 (en) * | 2002-06-12 | 2007-10-02 | Pacesetter, Inc. | Vagal stimulation for improving cardiac function in heart failure or CHF patients |
US20070255340A1 (en) * | 2006-04-28 | 2007-11-01 | Medtronic, Inc. | Electrical stimulation of iliohypogastric nerve to alleviate chronic pelvic pain |
US20070270675A1 (en) * | 2006-05-17 | 2007-11-22 | Michael John Kane | Implantable Medical Device with Chemical Sensor and Related Methods |
US20080009719A1 (en) * | 2006-06-06 | 2008-01-10 | Shuros Allan C | Method and apparatus for introducing endolymphatic instrumentation |
US20080260861A1 (en) * | 2004-04-07 | 2008-10-23 | The General Hospital Corporation | Modulating Lymphatic Function |
US7526337B2 (en) * | 2006-06-06 | 2009-04-28 | Cardiac Pacemakers, Inc. | Method and device for lymphatic system monitoring |
US20100042170A1 (en) * | 2006-06-06 | 2010-02-18 | Shuros Allan C | Method and apparatus for neural stimulation via the lymphatic system |
US7734341B2 (en) * | 2006-06-06 | 2010-06-08 | Cardiac Pacemakers, Inc. | Method and apparatus for gastrointestinal stimulation via the lymphatic system |
US7774055B1 (en) * | 2005-11-07 | 2010-08-10 | Pacesetter, Inc. | Left atrial pressure-based criteria for monitoring intrathoracic impedance |
US20100227807A1 (en) * | 2006-03-15 | 2010-09-09 | The Brigham And Women's Hospital, Inc. | Use of Gelsolin to Diagnose and Treat Inflammatory Desease (Stossel) |
US20110106202A1 (en) * | 2003-12-22 | 2011-05-05 | Jiang Ding | Method and system for setting cardiac resynchronization therapy parameters |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2637807B1 (en) * | 1988-10-14 | 1997-10-31 | Zacouto Fred | DEVICE FOR PROTECTION AGAINST BLOOD-RELATED CONDITIONS, IN PARTICULAR THROMBOSIS, EMBOLIES, HEMORRHAGIA, HEMOPATHIES AND PRESENCE OF ABNORMAL ELEMENTS IN THE BLOOD |
WO1993014694A1 (en) | 1992-01-16 | 1993-08-05 | The General Hospital Corporation | Method and apparatus for locating tumors |
JP2003327992A (en) * | 2002-05-08 | 2003-11-19 | Yoshiko Yamamoto | Essential oil composition and patch |
US7195594B2 (en) | 2002-05-14 | 2007-03-27 | Pacesetter, Inc. | Method for minimally invasive calibration of implanted pressure transducers |
US7769427B2 (en) | 2002-07-16 | 2010-08-03 | Magnetics, Inc. | Apparatus and method for catheter guidance control and imaging |
US7134999B2 (en) * | 2003-04-04 | 2006-11-14 | Dexcom, Inc. | Optimized sensor geometry for an implantable glucose sensor |
US7366572B2 (en) | 2004-03-16 | 2008-04-29 | Medtronic, Inc. | Controlling therapy based on sleep quality |
WO2007067690A2 (en) | 2005-12-07 | 2007-06-14 | Drexel University | Detection of blood pressure and blood pressure waveform |
US7894906B2 (en) | 2006-06-06 | 2011-02-22 | Cardiac Pacemakers, Inc. | Amelioration of chronic pain by endolymphatic stimulation |
-
2006
- 2006-06-06 US US11/422,417 patent/US7526337B2/en not_active Expired - Fee Related
-
2007
- 2007-04-19 JP JP2009514438A patent/JP5235014B2/en not_active Expired - Fee Related
- 2007-04-19 EP EP07797246A patent/EP2029003A2/en not_active Withdrawn
- 2007-04-19 WO PCT/US2007/066916 patent/WO2007146489A2/en active Application Filing
-
2009
- 2009-04-27 US US12/430,211 patent/US20090228059A1/en not_active Abandoned
Patent Citations (99)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3814080A (en) * | 1972-11-13 | 1974-06-04 | Becton Dickinson Co | Vessel cannulator and clamp for lymphangiography |
US3916875A (en) * | 1974-01-02 | 1975-11-04 | Herbert Toch | Lymph duct cannulation facilitator |
US4650467A (en) * | 1984-08-22 | 1987-03-17 | Sarcem S.A. | Remote control catheter |
US4909787A (en) * | 1986-08-14 | 1990-03-20 | Danforth John W | Controllable flexibility catheter with eccentric stiffener |
US4792330A (en) * | 1987-07-13 | 1988-12-20 | Lazarus Medical Innovations, Inc. | Combination catheter and duct clamp apparatus and method |
US5305745A (en) * | 1988-06-13 | 1994-04-26 | Fred Zacouto | Device for protection against blood-related disorders, notably thromboses, embolisms, vascular spasms, hemorrhages, hemopathies and the presence of abnormal elements in the blood |
US4957484A (en) * | 1988-07-26 | 1990-09-18 | Automedix Sciences, Inc. | Lymph access catheters and methods of administration |
US5405363A (en) * | 1991-03-15 | 1995-04-11 | Angelon Corporation | Implantable cardioverter defibrillator having a smaller displacement volume |
US5112303A (en) * | 1991-05-02 | 1992-05-12 | Pudenz-Schulte Medical Research Corporation | Tumor access device and method for delivering medication into a body cavity |
US5284153A (en) * | 1992-04-14 | 1994-02-08 | Brigham And Women's Hospital | Method for locating a nerve and for protecting nerves from injury during surgery |
US5333609A (en) * | 1992-05-19 | 1994-08-02 | Minnesota Mining And Manufacturing Company | Catheter and probe-catheter assembly |
US5387231A (en) * | 1992-07-21 | 1995-02-07 | Sporer; Patsy | Electrotherapy method |
US5391143A (en) * | 1993-03-12 | 1995-02-21 | Kensey Nash Corporation | Method and system for effecting weight reduction of living beings |
US5697953A (en) * | 1993-03-13 | 1997-12-16 | Angeion Corporation | Implantable cardioverter defibrillator having a smaller displacement volume |
US5596988A (en) * | 1993-06-30 | 1997-01-28 | Biomedical Sensors, Ltd. | Multi-parameter sensor apparatus |
US6129685A (en) * | 1994-02-09 | 2000-10-10 | The University Of Iowa Research Foundation | Stereotactic hypothalamic obesity probe |
US5658318A (en) * | 1994-06-24 | 1997-08-19 | Pacesetter Ab | Method and apparatus for detecting a state of imminent cardiac arrhythmia in response to a nerve signal from the autonomic nerve system to the heart, and for administrating anti-arrhythmia therapy in response thereto |
US5891084A (en) * | 1994-12-27 | 1999-04-06 | Lee; Vincent W. | Multiple chamber catheter delivery system |
US5662689A (en) * | 1995-09-08 | 1997-09-02 | Medtronic, Inc. | Method and apparatus for alleviating cardioversion shock pain |
US6321109B2 (en) * | 1996-02-15 | 2001-11-20 | Biosense, Inc. | Catheter based surgery |
US5655548A (en) * | 1996-09-16 | 1997-08-12 | Circulation, Inc. | Method for treatment of ischemic heart disease by providing transvenous myocardial perfusion |
US5865744A (en) * | 1996-09-16 | 1999-02-02 | Lemelson; Jerome H. | Method and system for delivering therapeutic agents |
US5817138A (en) * | 1996-11-27 | 1998-10-06 | Suzuki; James Y. | Multi-channel, interferential wave, micro current device and methods for treatment using micro current |
US6238423B1 (en) * | 1997-01-13 | 2001-05-29 | Medtronic, Inc. | Apparatus and method for treating chronic constipation |
US6475223B1 (en) * | 1997-08-29 | 2002-11-05 | Stereotaxis, Inc. | Method and apparatus for magnetically controlling motion direction of a mechanically pushed catheter |
US20070021731A1 (en) * | 1997-11-12 | 2007-01-25 | Garibaldi Jeffrey M | Method of and apparatus for navigating medical devices in body lumens |
US20030113303A1 (en) * | 1998-02-05 | 2003-06-19 | Yitzhack Schwartz | Homing of embryonic stem cells to a target zone in tissue using active therapeutics or substances |
US6024704A (en) * | 1998-04-30 | 2000-02-15 | Medtronic, Inc | Implantable medical device for sensing absolute blood pressure and barometric pressure |
US20020016615A1 (en) * | 1998-05-08 | 2002-02-07 | Dev Nagendu B. | Electrically induced vessel vasodilation |
US6347247B1 (en) * | 1998-05-08 | 2002-02-12 | Genetronics Inc. | Electrically induced vessel vasodilation |
US6292695B1 (en) * | 1998-06-19 | 2001-09-18 | Wilton W. Webster, Jr. | Method and apparatus for transvascular treatment of tachycardia and fibrillation |
US6272370B1 (en) * | 1998-08-07 | 2001-08-07 | The Regents Of University Of Minnesota | MR-visible medical device for neurological interventions using nonlinear magnetic stereotaxis and a method imaging |
US6370417B1 (en) * | 1998-09-22 | 2002-04-09 | Siemens Akiengesellschaft | Method for positioning a catheter in a vessel, and device for implementing the method |
US6115637A (en) * | 1998-12-22 | 2000-09-05 | Universities Research Association, Inc. | Microcurrent therapeutic technique for treatment of radiation toxicity |
US6077227A (en) * | 1998-12-28 | 2000-06-20 | Medtronic, Inc. | Method for manufacture and implant of an implantable blood vessel cuff |
US6106477A (en) * | 1998-12-28 | 2000-08-22 | Medtronic, Inc. | Chronically implantable blood vessel cuff with sensor |
US20010041870A1 (en) * | 1999-03-09 | 2001-11-15 | Edward M. Gillis | Implantable device for access to a treatment site |
US6835194B2 (en) * | 1999-03-18 | 2004-12-28 | Durect Corporation | Implantable devices and methods for treatment of pain by delivery of fentanyl and fentanyl congeners |
US6629534B1 (en) * | 1999-04-09 | 2003-10-07 | Evalve, Inc. | Methods and apparatus for cardiac valve repair |
US6368274B1 (en) * | 1999-07-01 | 2002-04-09 | Medtronic Minimed, Inc. | Reusable analyte sensor site and method of using the same |
US6804558B2 (en) * | 1999-07-07 | 2004-10-12 | Medtronic, Inc. | System and method of communicating between an implantable medical device and a remote computer system or health care provider |
US20040102804A1 (en) * | 1999-08-10 | 2004-05-27 | Chin Albert K. | Apparatus and methods for endoscopic surgical procedures |
US6741882B2 (en) * | 1999-12-02 | 2004-05-25 | Koninklijke Philips Electronics N.V. | MR device and MR method for localizing and/or visualizing a medical instrument provided with a passive magnet device |
US20010007924A1 (en) * | 1999-12-28 | 2001-07-12 | Tanita Corporation | Apparatus for detemining degree of restoration of diseased part |
US20040172102A1 (en) * | 2000-04-13 | 2004-09-02 | Cochlear Limited | At least partially implantable system for rehabilitation of a hearing disorder |
US6676686B2 (en) * | 2000-04-25 | 2004-01-13 | Harumi Naganuma | Noninvasive detection and activation of the lymphatic system in treating disease and alleviating pain |
US20010037061A1 (en) * | 2000-04-28 | 2001-11-01 | Rolf Eckmiller | Microcontact structure for neuroprostheses for implantation on nerve tissue and method therefor |
US6584362B1 (en) * | 2000-08-30 | 2003-06-24 | Cardiac Pacemakers, Inc. | Leads for pacing and/or sensing the heart from within the coronary veins |
US20020029037A1 (en) * | 2000-09-06 | 2002-03-07 | Kim Young D. | Method and apparatus for percutaneous trans-endocardial reperfusion |
US20050187584A1 (en) * | 2001-01-16 | 2005-08-25 | Stephen Denker | Vagal nerve stimulation using vascular implanted devices for treatment of atrial fibrillation |
US20020123674A1 (en) * | 2001-03-01 | 2002-09-05 | Gianni Plicchi | Process and implantable device for the intrapulmonary assessing of density dependant physical properties of the lung tissue |
US20020156462A1 (en) * | 2001-04-18 | 2002-10-24 | Stultz Mark R. | Programmable implantable pump with accessory reservoirs and multiple independent lumen catheter |
US20020188253A1 (en) * | 2001-06-07 | 2002-12-12 | Pharmaspec Corporation | Method and apparatus for drug delivery in veins |
US20030018247A1 (en) * | 2001-06-29 | 2003-01-23 | George Gonzalez | Process for testing and treating aberrant sensory afferents and motors efferents |
US20040158297A1 (en) * | 2001-06-29 | 2004-08-12 | George Gonzalez | Process for testing and treating motor and muscle function, sensory, autonomic, cognitive and neurologic disorders |
US20030036773A1 (en) * | 2001-08-03 | 2003-02-20 | Whitehurst Todd K. | Systems and methods for treatment of coronary artery disease |
US6893429B2 (en) * | 2001-08-30 | 2005-05-17 | Medtronic, Inc. | Convection enhanced delivery catheter to treat brain and other tumors |
US20030078623A1 (en) * | 2001-10-22 | 2003-04-24 | Weinberg Lisa P. | Implantable lead and method for stimulating the vagus nerve |
US20050149014A1 (en) * | 2001-11-15 | 2005-07-07 | Quantumcor, Inc. | Cardiac valve leaflet attachment device and methods thereof |
US20030105506A1 (en) * | 2001-12-04 | 2003-06-05 | Cardiac Pacemakers, Inc. | Apparatus and method for stabilizing an implantable lead |
US20030204185A1 (en) * | 2002-04-26 | 2003-10-30 | Sherman Marshall L. | System and method for monitoring use of disposable catheters |
US7277761B2 (en) * | 2002-06-12 | 2007-10-02 | Pacesetter, Inc. | Vagal stimulation for improving cardiac function in heart failure or CHF patients |
US7123961B1 (en) * | 2002-06-13 | 2006-10-17 | Pacesetter, Inc. | Stimulation of autonomic nerves |
US20040006795A1 (en) * | 2002-06-13 | 2004-01-08 | Mcgonigle Brian | Methods to increase the isoflavonoid levels in plants and plants producing increased levels of isoflavonoids |
US20050143765A1 (en) * | 2002-09-04 | 2005-06-30 | Endoart Sa | Telemetrically controlled band for regulating functioning of a body organ or duct, and methods of making, implantation and use |
US6918873B1 (en) * | 2002-09-19 | 2005-07-19 | Millar Instruments, Inc. | Inverted sensor module |
US20040106953A1 (en) * | 2002-10-04 | 2004-06-03 | Yomtov Barry M. | Medical device for controlled drug delivery and cardiac monitoring and/or stimulation |
US20040172080A1 (en) * | 2002-12-04 | 2004-09-02 | Stadler Robert W. | Method and apparatus for detecting change in intrathoracic electrical impedance |
US20050080346A1 (en) * | 2002-12-16 | 2005-04-14 | The Regents Of The University Of Michigan | Antenna stent device for wireless, intraluminal monitoring |
US20040210118A1 (en) * | 2003-04-18 | 2004-10-21 | Michel Letort | In situ detection of endoleak and endotension |
US20050043675A1 (en) * | 2003-08-21 | 2005-02-24 | Pastore Joseph M. | Method and apparatus for modulating cellular metabolism during post-ischemia or heart failure |
US20050043894A1 (en) * | 2003-08-22 | 2005-02-24 | Fernandez Dennis S. | Integrated biosensor and simulation system for diagnosis and therapy |
US20050049472A1 (en) * | 2003-08-29 | 2005-03-03 | Medtronic, Inc. | Implantable biosensor devices for monitoring cardiac marker molecules |
US20050075701A1 (en) * | 2003-10-01 | 2005-04-07 | Medtronic, Inc. | Device and method for attenuating an immune response |
US20050075702A1 (en) * | 2003-10-01 | 2005-04-07 | Medtronic, Inc. | Device and method for inhibiting release of pro-inflammatory mediator |
US20060149331A1 (en) * | 2003-12-19 | 2006-07-06 | Brian Mann | Method for digital cardiac rhythm management |
US7616991B2 (en) * | 2003-12-19 | 2009-11-10 | Pacesetter, Inc. | Method for digital cardiac rhythm management |
US20110106202A1 (en) * | 2003-12-22 | 2011-05-05 | Jiang Ding | Method and system for setting cardiac resynchronization therapy parameters |
US20060030837A1 (en) * | 2004-01-29 | 2006-02-09 | The Charles Stark Draper Laboratory, Inc. | Drug delivery apparatus |
US20050240243A1 (en) * | 2004-02-25 | 2005-10-27 | Giancarlo Barolat | System and method for neurological stimulation of peripheral nerves to treat low back pain |
US20080260861A1 (en) * | 2004-04-07 | 2008-10-23 | The General Hospital Corporation | Modulating Lymphatic Function |
US20050246006A1 (en) * | 2004-04-30 | 2005-11-03 | Algotec Limited | Electrical nerve stimulation device |
US20060020333A1 (en) * | 2004-05-05 | 2006-01-26 | Lashinski Randall T | Method of in situ formation of translumenally deployable heart valve support |
US7260431B2 (en) * | 2004-05-20 | 2007-08-21 | Cardiac Pacemakers, Inc. | Combined remodeling control therapy and anti-remodeling therapy by implantable cardiac device |
US20050261741A1 (en) * | 2004-05-20 | 2005-11-24 | Imad Libbus | Combined remodeling control therapy and anti-remodeling therapy by implantable cardiac device |
US20050267440A1 (en) * | 2004-06-01 | 2005-12-01 | Herman Stephen J | Devices and methods for measuring and enhancing drug or analyte transport to/from medical implant |
US20060074453A1 (en) * | 2004-10-04 | 2006-04-06 | Cvrx, Inc. | Baroreflex activation and cardiac resychronization for heart failure treatment |
US20060149337A1 (en) * | 2005-01-21 | 2006-07-06 | John Michael S | Systems and methods for tissue stimulation in medical treatment |
US20060247601A1 (en) * | 2005-04-19 | 2006-11-02 | Ellin Philip J | Method of improved drug delivery and for treatment of cellulitis |
US20070027460A1 (en) * | 2005-07-27 | 2007-02-01 | Cook Incorporated | Implantable remodelable materials comprising magnetic material |
US7774055B1 (en) * | 2005-11-07 | 2010-08-10 | Pacesetter, Inc. | Left atrial pressure-based criteria for monitoring intrathoracic impedance |
US20100227807A1 (en) * | 2006-03-15 | 2010-09-09 | The Brigham And Women's Hospital, Inc. | Use of Gelsolin to Diagnose and Treat Inflammatory Desease (Stossel) |
US20070255340A1 (en) * | 2006-04-28 | 2007-11-01 | Medtronic, Inc. | Electrical stimulation of iliohypogastric nerve to alleviate chronic pelvic pain |
US20070270675A1 (en) * | 2006-05-17 | 2007-11-22 | Michael John Kane | Implantable Medical Device with Chemical Sensor and Related Methods |
US20080009719A1 (en) * | 2006-06-06 | 2008-01-10 | Shuros Allan C | Method and apparatus for introducing endolymphatic instrumentation |
US7526337B2 (en) * | 2006-06-06 | 2009-04-28 | Cardiac Pacemakers, Inc. | Method and device for lymphatic system monitoring |
US20100042170A1 (en) * | 2006-06-06 | 2010-02-18 | Shuros Allan C | Method and apparatus for neural stimulation via the lymphatic system |
US7734341B2 (en) * | 2006-06-06 | 2010-06-08 | Cardiac Pacemakers, Inc. | Method and apparatus for gastrointestinal stimulation via the lymphatic system |
US20100217346A1 (en) * | 2006-06-06 | 2010-08-26 | Shuros Allan C | Method and apparatus for gastrointestinal stimulation via the lymphatic system |
Cited By (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8369943B2 (en) | 2006-06-06 | 2013-02-05 | Cardiac Pacemakers, Inc. | Method and apparatus for neural stimulation via the lymphatic system |
US20080009719A1 (en) * | 2006-06-06 | 2008-01-10 | Shuros Allan C | Method and apparatus for introducing endolymphatic instrumentation |
US8897878B2 (en) | 2006-06-06 | 2014-11-25 | Cardiac Pacemakers, Inc. | Method and apparatus for gastrointestinal stimulation via the lymphatic system |
US20070282386A1 (en) * | 2006-06-06 | 2007-12-06 | Shuros Allan C | Method and apparatus for gastrointestinal stimulation via the lymphatic system |
US7734341B2 (en) | 2006-06-06 | 2010-06-08 | Cardiac Pacemakers, Inc. | Method and apparatus for gastrointestinal stimulation via the lymphatic system |
US7894906B2 (en) | 2006-06-06 | 2011-02-22 | Cardiac Pacemakers, Inc. | Amelioration of chronic pain by endolymphatic stimulation |
US20070282390A1 (en) * | 2006-06-06 | 2007-12-06 | Shuros Allan C | Amelioration of chronic pain by endolymphatic stimulation |
US8126538B2 (en) | 2006-06-06 | 2012-02-28 | Cardiac Pacemakers, Inc. | Method and apparatus for introducing endolymphatic instrumentation |
US8905999B2 (en) | 2006-09-01 | 2014-12-09 | Cardiac Pacemakers, Inc. | Method and apparatus for endolymphatic drug delivery |
US20080195171A1 (en) * | 2007-02-13 | 2008-08-14 | Sharma Virender K | Method and Apparatus for Electrical Stimulation of the Pancreatico-Biliary System |
US9037244B2 (en) | 2007-02-13 | 2015-05-19 | Virender K. Sharma | Method and apparatus for electrical stimulation of the pancreatico-biliary system |
US11517749B2 (en) | 2008-10-09 | 2022-12-06 | Virender K. Sharma | Methods and apparatuses for stimulating blood vessels in order to control, treat, and/or prevent a hemorrhage |
US10376694B2 (en) | 2008-10-09 | 2019-08-13 | Virender K. Sharma | Method and apparatus for stimulating the vascular system |
US10603489B2 (en) | 2008-10-09 | 2020-03-31 | Virender K. Sharma | Methods and apparatuses for stimulating blood vessels in order to control, treat, and/or prevent a hemorrhage |
US20110276023A1 (en) * | 2010-05-04 | 2011-11-10 | Leeflang Stephen A | Apparatus and Methods for Accessing the Lymphatic System |
US9421316B2 (en) * | 2010-05-04 | 2016-08-23 | Stephen A. Leeflang | Apparatus and methods for accessing the lymphatic system |
WO2015200797A3 (en) * | 2014-06-26 | 2016-02-18 | The Trustees Of The University Of Pennsylvania | Devices and methods for alleviating lymphatic system congestion |
US10639458B2 (en) | 2014-06-26 | 2020-05-05 | The Trustees Of The University Of Pennsylvania | Devices and methods for alleviating lymphatic system congestion |
Also Published As
Publication number | Publication date |
---|---|
US20070282382A1 (en) | 2007-12-06 |
JP2009539488A (en) | 2009-11-19 |
JP5235014B2 (en) | 2013-07-10 |
EP2029003A2 (en) | 2009-03-04 |
WO2007146489A3 (en) | 2008-02-14 |
US7526337B2 (en) | 2009-04-28 |
WO2007146489A2 (en) | 2007-12-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US7526337B2 (en) | Method and device for lymphatic system monitoring | |
US8126538B2 (en) | Method and apparatus for introducing endolymphatic instrumentation | |
US8905999B2 (en) | Method and apparatus for endolymphatic drug delivery | |
US20080294228A1 (en) | Method and device for controlled stimulation of lymphatic flow | |
US6999816B2 (en) | Detecting heart tones to identify heart deterioration | |
US8672917B2 (en) | Pressure monitoring to control delivery of therapeutic agent | |
US8744544B2 (en) | System having wireless implantable sensor | |
US7604629B2 (en) | Multi-parameter infection monitoring | |
US8613705B2 (en) | Central venous pressure sensor and method to control a fluid or volume overload therapy | |
EP1610859B1 (en) | Apparatus for evaluating and optimizing ventricular synchronization | |
US9943236B2 (en) | Methods for guiding heart failure decompensation therapy | |
US7611483B2 (en) | Indicator metrics for infection monitoring | |
EP0985429A2 (en) | Medical device | |
EP2182837A1 (en) | Lung fluid status monitoring using acoustic energy | |
US9950175B2 (en) | Remote closed-loop titration of decongestive therapy for the treatment of advanced heart failure | |
US7766862B2 (en) | Baseline acquisition for infection monitoring | |
US20220362557A1 (en) | Detection of infection based on temperature and impedance | |
US10695484B1 (en) | Systems and methods for lumbar cerebrospinal fluid access and treatment | |
US20220031184A1 (en) | Dynamic bio impedance range adjustment for a medical device |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- AFTER EXAMINER'S ANSWER OR BOARD OF APPEALS DECISION |